• Plans are already in place to expand Grapefruit’s state-of-the-art extraction facility
• The company is dedicated to distributing its own products and providing high-quality cannabis commodities to customers
• Grapefruit’s newest product demonstrates the company’s capabilities and serves as a flagship of its edibles line

Grapefruit Boulevard Investments Inc. (OTCQB: IGNG), a fully licensed cannabis manufacturer and distributor in California, is fast becoming recognized in the industry for its quality product lines. Those products – including Rainbow Dreams, Grapefruit’s most recent offering – adhere strictly to the company’s motto and commitment to offer “a high you can trust.”

That commitment starts at the heart of the company’s operations – its fully licensed and compliant ethanol extraction laboratory located in the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. Widely recognized as a hub for quality cannabis activity, the Coachillin’ location is the perfect backdrop for Grapefruit’s manufacturing and distribution operations.

Grapefruit began extraction in May and already has expansion plans in place that will allow the growing company to increase efficiencies and output. The company plans to build a state-of-the-art, all-inclusive facility that will house a 50,000-square-foot-plus indoor grow canopy and large extraction lab; a manufacturing space to produce its vape lines and CBD products; an FDA-certified kitchen for the production of Grapefruit edibles; and a distribution facility for selling all products throughout the entire cannabis marketplace. The new structure is expected to be built adjacent to the company’s current operations in the Coachillin’ park.

Grapefruit’s dedication to quality and service means that, in addition to being able to offer a large and diverse inventory of superior cannabis products that can be delivered within 24 hours of order, the company’s wholesale distribution arm will also offer high-quality, competitively priced raw materials to other manufacturers and distributors. Grapefruit’s extraction lab produces high-quality distillate or ‘honey oil’, a universal product used in everything from infused edibles and tinctures/creams to the ‘fuel’ used in vapes and e-cigarettes. Honey oil is a highly sought out item on the cannabis market, and Grapefruit’s commitment to premium quality ingredients will enable the company to demand top dollar for its cannabis products. Utilizing biomass cultivated in its own indoor grow canopy operation, Grapefruit aims to position itself for high revenue potential.

In addition to expanding its extraction lab, Grapefruit recently strengthened its position as a growing presence in the cannabis space with the launch of its newest brand, Rainbow Dreams, a unique line of newly formulated and flavored CBD- and THC-infused cannabis oil vaporization cartridges. Rainbow Dreams is made from the most trusted oils and highest-quality, authentic CCELL ceramic vaporizer cartridges, ensuring the most consistent and smooth product delivery available in the industry today. The four new Rainbow Dream vape cartridges each offer a unique flavor profile, including mango passion, citrus bliss, berry delight and strawberry ice.

“Moving the Rainbow Dreams project forward demonstrates our team’s ability to bring a high-quality product to market at a competitive price,” Grapefruit CEO Bradley J. Yourist stated in a news release (http://ibn.fm/gLj02). “Flavored and full-spectrum cannabis oils… are growing in popularity in California and elsewhere because customers in the recreational market want a no burn-flavored oil without any offending cannabis smell. Our Rainbow Dreams products deliver on this… It is our experience that some customers like a more CBD- and CBN-heavy formulated oil for help with pain and sleep.”

Yourist indicated that Rainbow Dreams will be the flagship for Grapefruit’s new cartridges, which are planned for release within the next 45 days.

“By implementing our own high-end, custom-formulated vaporization cartridge line, Grapefruit believes it will capture significant revenue opportunities as we move inexorably toward our goal of becoming a leading, fully integrated, licensed and compliant cannabis-product manufacturing and distribution company,” Yourist added.

Grapefruit holds California licenses to both manufacture and distribute cannabis products. The company’s vision is to become a seed-to-sale, fully vertically integrated, ethical and compliant cannabis and CBD product company. The company works to manufacture, procure and distribute only the highest-quality, all-natural cannabis honey oil, edibles, flowers, concentrates and related products that are free from pesticides, heavy metals and bacteria.

For more information, visit the company’s website at www.GrapefruitBlvd.com

NOTE TO INVESTORS: The latest news and updates relating to IGNG are available in the company’s newsroom at http://ibn.fm/IGNG

• Health Canada is enforcing mandatory cannabis testing for the presence of pesticide active ingredients; unauthorized pesticide use can result in seizure or recall of product, suspension/revocation of licenses and penalties of up to $1 million
• MustGrow is seeking Health Canada approval for its patented biopesticide as a natural, pre-pot soil treatment for soil-borne pests and diseases that affect cannabis production
• A joint research and development program with the National Research Council Canada is underway, with a focus on the efficacy of MustGrow’s biopesticides for use in cannabis production
• MustGrow’s safe and effective natural products are EPA- and PRMA-approved and registered for use on fruits, vegetables, turf and ornamental crops

MustGrow Biologics Corp. (CSE: MGRO), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizer products for the cannabis industry, is continuing its joint research and development program with the National Research Council Canada (NRC). The NRC is an agency of the government of Canada whose research and development divisions are focused on supporting innovation efforts in key industry sectors, including the rapidly expanding cannabis marketplace (http://ibn.fm/gCar2).

MustGrow’s biopesticide R&D program with the NRC targets an issue plaguing licensed cannabis producers who must follow regulatory guidelines when it comes to using pesticides or pest control products (“PCP”) in growing and manufacturing cannabis products. Under the Cannabis Act, license holders may only use certain PCPs that have been approved for use on cannabis by the Pest Management and Regulatory Agency (http://ibn.fm/liqhz).

MustGrow and the NRC are conducting a series of efficacy assessments of MustGrow’s patented natural biopesticide as a natural pre-plant, pre-pot soil treatment for soil-borne pests and diseases that affect cannabis production (http://ibn.fm/T5jTD). MustGrow’s products are refined from compounds of the mustard plant, utilizing the plant’s natural defense mechanism as a pre-plant soil biopesticide treatment (http://ibn.fm/UAulS) and are shown to deliver effective pathogen and pest control to ensure plant growth and high yields in a variety of agricultural settings (http://ibn.fm/zsuSl).

Canada’s licensed producers (LPs) are required by law to demonstrate that no unauthorized pesticides were used on their products or contaminated them (http://ibn.fm/oo6wQ), and mandatory testing is underway to ensure that LPs comply. Failure of Health Canada’s sampling and testing program for unauthorized pest control products could result in product seizure or destruction, recall of products sold, suspension or revocation of the firm’s license, or a monetary penalty of up to C$1 million, according to Health Canada.

Through MustGrow’s eventual suite of biostimulant/biofertilizer offerings, Canadian cannabis license holders may have access to products that aid in the production of compliant, pest-free cannabis. MustGrow’s science-based suite of signature products have already demonstrated control of many soil-borne diseases and pests that affect cannabis production, including Botrytis (grey mold), Pythium root rot, Rhizoctonia fungus, Fusarium, nematodes, Verticillium wilt, Phytophthora root rot and Sclerotinia. MustGrow’s products are recognized as safe and are EPA- and PRMA-approved for use on fruits and vegetables.

For more information, visit the company’s website at www.MustGrow.ca

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://ibn.fm/MGRO

• SinglePoint is building an extensive portfolio of undervalued subsidiaries
• The company recently gave a shareholder overview detailing its new initiatives
• SinglePoint’s merchant services portfolio continues to grow

SinglePoint Inc. (OTCQB: SING) specializes in acquisitions of small to mid-sized firms and is focused on diversification into horizontal markets. The company’s emphasis is on new technologies, and its varied assets include payment processing, cannabis and more. Headquartered in Phoenix, Arizona, SinglePoint provides investors with an opportunity to gain exposure to a broad array of assets.

SinglePoint is building an impressive portfolio of undervalued subsidiaries that offer a varied holding base with multiple streams of revenue (http://ibn.fm/2Kov4). The company is taking advantage of its technological expertise to develop opportunities in the cannabis market, and, since 2014, SinglePoint has been providing ancillary solutions and investing in or acquiring businesses that provide services or offerings to the hemp and cannabis industries.

SinglePoint is eyeing opportunities to implement its payments expertise into accounts including CBD and cannabis clients. The company can support online and instore payments for business of all kinds and plans to continue alternative payments rollouts through the use of blockchain-based solutions.

Recently, SinglePoint provided a shareholder update overviewing its important growth initiatives. These initiatives involve solar, hemp and merchant services. The company’s most recent acquisition was that of Direct Solar, whose offerings span both commercial solar applications and renewable-energy financing options. Direct Solar enables residential solar customers to shop their options so that they can find the best offerings for their homes (http://ibn.fm/vw8gU).

Fundamentally, Direct Solar offers an innovative solution for lenders, building owners and management teams. For lenders, the firm provides verified projects with vetted services providers. Lenders offer Direct Solar their lists of requirements in order to fund a project. Subsequently, lenders receive only projects that fit within those parameters. For commercial customers, Direct Solar provides a one-stop shop where they can apply for and receive financing for their projects upon approval. In its first 60 days, Direct Solar contracted more than $3 million in residential solar contracts.

Furthermore, SinglePoint has its hemp-derived CBD (cannabidiol) offerings. SingleSeed is the company’s consumer-facing CBD brand, and it has been progressively building sales via its ecommerce site, SingleSeed.com. SingleSeed is now working on distribution agreements to bring hemp-derived CBD products to retail stores.

Moreover, SingleSeed is leveraging opportunities to manufacture products for consumers. Through its DIGS subsidiary, SingleSeed has leased a property in Carlsbad, California, to manufacture and distribute products ranging from hemp topicals to tinctures and capsules.

SinglePoint is also concentrating once again on payments and merchant services. The company is working to take on all kinds of businesses, including high-risk ventures such as cannabis and hemp, auto mechanic shops and restaurants. SinglePoint has acquired many new merchants recently and is currently building its strategy around bringing in more contractors to quickly scale its merchant services team.

SinglePoint continues to focus on its strategy to drive revenue growth through partnerships, equity-financed acquisitions and internal product development. The company offers investors a door to emerging technologies that have the potential for significant ROI, putting SinglePoint at the vanguard of innovation in new verticals.

For more information, visit the company’s website at www.SinglePoint.com

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

• MustGrow Biologics is building on positive results from testing of its mustard-based pest control product, with plans to develop a concentrated liquid form that it can market to the tobacco industry
• MustGrow’s focus on natural, safe and effective means of pest control positions it to meet the needs of the agricultural industry at a time when pesticide toxicity is an increasing concern to businesses and consumers
• MustGrow is also developing a suite of products that is expected to fill the organic pest control needs of the burgeoning cannabis industry

MustGrow Biologics Corp. (CSE: MGRO) is advancing its efforts to be a standard-bearer in the search for natural remedies to prevent pest damage in high value agricultural crops, including tobacco and cannabis, while news about chemical pesticide injuries continues to trouble the larger industry and its ancillary segments.

For years, MustGrow has been researching the effectiveness of organic mustard seed-based granules in fending off parasitic worms known as nematodes that harm tobacco industry productivity. These pests reduce statewide tobacco production by an estimated two percent each year in Virginia alone, according to a company news release (http://ibn.fm/QQPAO).

The company’s statement noted that the pre-plant granules resulted in significantly reduced nematode population density when applied at rates of more than 500 pounds per acre, and the findings are leading the company to develop a concentrated second-generation liquid formulation that could allow for lower usage amounts due to its higher concentration. As the new round of testing is completed on specific soilborne diseases, MustGrow intends to seek regulatory approvals for its formulation as an organic biopesticide that targets the needs of tobacco growers.

At the same time, MustGrow is hoping to expand on its fruit and vegetable pest control offerings by pulling together a suite of biological products from third parties, which the company aims to in-license and/or distribute for pests affecting licensed producers (LPs) in Canada’s burgeoning cannabis industry. Triangle Plant Science’s TP-1000, which improves nutrient effectiveness in plants to help them grow quicker and flower better, is the first third-party product adopted by MustGrow under its cannabis strategy. TP-1000 has shown its ability, in independent trials, to boost plant yield as well as terpene and THC levels, according to the company (http://ibn.fm/NHtDw).

The importance of improving defenses against nematodes was demonstrated when Bayer announced July 30 that it has canceled plans for broad distribution of its NemaStrike Technology amid ongoing concerns about rashes in a small number of people exposed to the pesticide or treated products, according to Reuters (http://ibn.fm/lByf3).

The Reuters report noted that Monsanto, which was acquired by Bayer last year, had planned to launch its “blockbuster” Environmental Protection Agency (EPA)-approved technology on up to eight million acres of crops in the United States during 2018, but called off the proposal following reports of rashing in some people.

An August 1 report on Brazil’s agricultural industry noted that the rising exporter is also beset by chemical pesticide concerns, with a potential international impact following the government’s adoption of a regulatory framework that identifies risk of death as the only criteria for determining how toxic pesticides may be labeled (http://ibn.fm/FkcEW). The change accompanies reports of increasing exposure to toxic pesticides among rural residents who live near fields.

MustGrow’s focus on only using safe, natural products that are scientifically shown to be effective alternatives to chemicals positions the company to fill genuine, life-sustaining needs from the agricultural industry. Its products have been tested on a commercial scale and carry minimal regulatory concerns, having already been granted approvals by the U.S. Environmental Protection Agency (EPA) and Canadian Pest Management Regulatory Agency (PMRA).

For more information, visit the company’s website at www.MustGrow.ca

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://ibn.fm/MGRO

• SGMD is commencing hemp cultivation by exercising an investment option in Hempistry Inc.
• Hempistry has a site in Madisonville, Hopkins County, Kentucky, where it is cultivating a fast-growing strain of hemp that’s rich in cannabidiol
• Hemp Business Journal reports that hemp generated more than $1 billion in revenues in the U.S. in 2018; the market is projected to reach $1.9 billion by 2022

Sugarmade Inc. (OTCQB: SGMD), a supplier of hydroponic and cultivation equipment to operators in the booming industrial hemp sector, has commenced hemp cultivation with Hempistry Inc. in Madison County, Kentucky. Sugarmade also announced that it is exercising its investment option in Hempistry as it intensifies its supplier and investor roles in the market (http://ibn.fm/C87U1).

Hempistry is cultivating a fast-growing strain of hemp that’s rich in cannabidiol. Although Sugarmade is not in the hemp cultivation business itself, the company has a business model focused on supporting and supplying hemp industry cultivators.

According to Hemp Business Journal, the hemp market in the Unites States was estimated to reach more than $1 billion in 2018, with growth forecasts calling for a 14.4 percent five-year CAGR to $1.9 billion through 2022 (http://ibn.fm/5XuiI). Hemp-derived CBD is projected to be the leading category of seven different sectors of hemp-based product sales by 2022.

Sugarmade CEO Jimmy Chan said in a news release (http://ibn.fm/6lk06) that SGMD has “multiple options for growth, while (its) recently effective S-1 filing expands (Sugarmade’s) ability to finance the many initiatives in front of the company.” SGMD is exploring the next generation of hemp-processing technology. The intersection of rising demand and the legal relief provided by the passage of the 2018 Farm Bill is expected to result in a peak industrial hemp crop in 2019. Hemp production is flourishing in Kentucky, as it leads the nation in quantity of cultivated acres, and SGMD’s commitment to the state is evident through its relationships with cultivators and suppliers like Hempistry and BZRTH.

Despite hemp’s current desirability in the United States, the crop has not always been so popular. It had been cultivated for its fibers for centuries before falling out of style in the 20th century, when it became entangled with efforts to criminalize drugs. As American businesses are getting into the hemp extraction market, they are finding themselves ill-equipped, lacking the advanced technology and expertise to produce on a large scale. Despite the industry’s dearth of technological advancement, Sugarmade has set itself up as an emerging leader in providing hemp extraction equipment. China has a more advanced hemp fiber industry, and SGMD has been working with Chinese extractors to usher in the newest technologies in hemp extraction (http://ibn.fm/pzI5b). The company now has the ability to supply high efficiency extraction equipment but is exclusively working with a limited number of ‘mega producers’.

Based in the Los Angeles-suburb of Monrovia, California, Sugarmade is a hydroponics and cultivation supply company that’s committed to supporting the industrial hemp sector. The company is also a product and brand marketing firm with numerous operations, such as packaging and paper goods for diverse industries.

For more information, visit the company’s website at www.Sugarmade.com

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

• PBIO expects to achieve a significant revenue increase in 2019 and beyond through the expansion of its proprietary BaroFold platform into the estimated $44 billion global bioprocess technology market
• Over 200 therapeutic proteins and peptides are currently approved by the FDA for use with conditions such as cancer, immunological and metabolic disorders and infectious diseases
• Hundreds of additional protein and peptide-based drugs are in development worldwide
• PBIO’s proprietary BaroFold platform offers a unique and cost-effective way to address two of the most complex and challenging issues critical to the development and manufacture of therapeutic proteins

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based technologies and products to the worldwide life sciences and other industries, recently announced its execution of a contract services agreement with a world-renowned, multibillion-dollar biotherapeutics firm. Under the terms of the agreement, the firm will utilize PBIO’s proprietary BaroFold(TM) technology platform to enhance the process manufacturing of one of its candidate protein drugs (http://ibn.fm/aidN2).

PBIO’s BaroFold technology platform offers a unique and cost-effective way to address the complex and often challenging process of manufacturing the recombinant proteins that are required in the development of protein-based drugs. Two of the major challenges associated with manufacturing recombinant proteins are (1) the formation of aggregates and (2) protein misfolding. These are significant issues that can prevent a protein drug candidate from ever making it to market.

“The BaroFold platform can be applied to the development and production of many different therapeutic proteins, can improve product safety, and is scalable and practical for standard bioprocess environments,” Dr. Alexander Lazarev, PBIO’s chief science officer, stated in a news release. “Moreover, it offers ways to reduce or eliminate the use of aggressive chemicals in the protein manufacturing process. We believe this unique technology platform can help biopharmaceutical companies create and manufacture high quality novel protein therapeutics and biosimilars, lower the cost of existing formulations, and help protect our environment.”

Protein-based therapeutics are a large and growing part of the global health care industry. Based on data in the THPdb database (http://ibn.fm/0TGzt), there are over 200 therapeutic proteins and peptides currently approved by the FDA for clinical use in the United States. These target therapies have shown significantly improved outcomes for many patients suffering from severe medical conditions, such as cancer and immunological diseases. The global protein drug market is projected to reach nearly $249 billion by 2020 at a compound annual growth rate of 7.3 percent from 2015 to 2020, according to data from Research and Markets (http://ibn.fm/i4Pu7).

PBIO’s recently launched Biopharma Services Business – based on its patented BaroFold technology platform – also provides the company with a unique opportunity to enter the global bioprocess technology market, which Transparency Market Research expects to be valued at an estimated $44 billion by 2026 (http://ibn.fm/aPMP0).

“In addition to successfully performing contract services for two biopharmaceutical companies since the beginning of 2019, we are also in discussions with three additional bio-therapeutic companies interested in utilizing our proprietary BaroFold services for their protein drug candidates,” Richard T. Schumacher, president and CEO of PBIO, stated in a news release. “To take full advantage of this opportunity, we have doubled the capacity of our contract services team, purchased additional sophisticated equipment, and developed new high-pressure concepts that further improve and enhance our BaroFold process scalability and its GMP compliance.”

“We believe our recently launched Biopharma Services Business could add as much as $500,000 to 2019 total revenue and significantly more to total revenue for 2020 and beyond,” Schumacher concluded. “It is important to note that these estimates do not include the anticipated growth in Barocycler 2320EXT sales that we believe will result from biotechnology and biopharmaceutical companies developing their own manufacturing, quality control, and protein characterization applications on our leading PCT-based instrument system.”

In addition to its new Biopharma Services Business, the company develops and markets high-pressure instruments for scientific research purposes throughout the United States, Canada, Europe, Australia and Asia. To date, PBIO has installed approximately 350 pressure cycling technology (PCT) systems (Barocycler, Barozyme, HUB) in nearly 200 leading academic, government, biotech and pharma laboratories around the world, while its PCT platform continues to be prominently featured in a record number of international science conferences (http://ibn.fm/hSPKV).

The company recently announced that it will be entering the rapidly growing CBD market with its newly designed BaroShear K45 instrument. Based on its proprietary Ultra Shear Technology (UST) platform, the company believes that BaroShear K45 sales in 2020 will result in a doubling of current 2019 revenue. Besides the CBD market, this revolutionary processing system is also expected to attract customers spanning multiple markets, including pharmaceuticals, cosmetics, nutraceuticals, food and beverage, and more.

For more information, visit the company’s website at www.PressureBioSciences.com

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

• Its acquisition of 50 percent of operating rights pertaining to oil sands in Utah is expected to help increase Petroteq’s cash value
• The company has also announced plans to satisfy debts with common shares so as to preserve its cash for the extraction technology being utilized at its Asphalt Ridge asset, as well as for working capital
• The acquisition is an important part of Petroteq’s extraction strategy, which is reliant on the company’s Clean Oil Recovery Technology that ensures safe, sustainable and environment-friendly oil extraction

On July 22, 2019, Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) announced the finalization of its acquisition of 50 percent of the operating rights and interests pertaining to oil sands in the state of Utah under the U.S. federal oil and gas leases. The acquisition encompasses 8,480 gross acres, or 4,240 net acres. All of the shares issued pursuant to the transaction will be subject to a four-month hold period, according to a company news release (http://ibn.fm/tDmGd).

Petroteq, a fully integrated surface oil sands mining company with proprietary technology, delivered a number of additional important news in connection with its operation and strategic growth plans.

The company released details regarding the issuance of a $300,000 principal amount (including an original issue discount of 20 percent) unsecured convertible debenture, as well as warrants exercisable for up to 1,315,789 common Petroteq shares at a cost of $0.24 per share for 15 months.

The debenture bears an interest rate of seven percent per year. It is payable quarterly, and, at the option of the holder, the purchase amount is convertible to 1,315,789 common shares of the company at $0.19 per share.

Finally, Petroteq has agreed to complete a shares-for-debt transaction, after which the company will issue 838,714 common shares in satisfaction of $176,130 of indebtedness that’s currently owed. The decision to satisfy the indebtedness with common shares will enable Petroteq to preserve cash for the important purposes of working capital and the implementation of its extraction technology at its Asphalt Ridge site in Utah.

Petroteq, an oil and gas extraction innovator, has developed its own Clean Oil Recovery Technology (CORT) that’s suitable for surface tar sands oil extraction in Utah. CORT is a closed-loop system that extracts fuel oils from the ground and returns the “cleaned” sand after the completion of the process.

The company is focused on the development of proprietary new extraction technologies. It targets sustainable and environment-friendly techniques for the extraction of heavy bitumen from oil sands, oil shale deposits and shallow oil deposits. The proprietary technology produces no greenhouse emissions and zero waste while also requiring no high temperatures.

Currently, Petroteq is focusing its mining efforts on resource-rich areas of Utah. U.S. Department of Energy estimates suggest that the state’s recoverable oil resources comprise of over 30 billion barrels (http://ibn.fm/ywd7r). As per engineer estimates, there are 139.5 million standard tank barrels of bitumen at Petroteq’s Asphalt Ridge site.

Through the acquisition of the additional operating rights announced on July 22, Petroteq is expected to increase its cash flow value. One of the leases, P.R. Spring, is believed to contain gross contingent resources of about 90 million barrels of mineable bitumen, with a net arithmetic average after risk estimate of 40.77 million barrels. According to Petroteq, the resource amounts to an after-risk cash flow value of $293.4 million on a 10 percent per year discounted basis and a cash flow value of $166.6 million on a 15 percent per year discounted basis.

For more information, visit the company’s website at www.Petroteq.energy

NOTE TO INVESTORS: The latest news and updates relating to PQEFF are available in the company’s newsroom at http://ibn.fm/PQEFF

• City View Green Holdings is advancing its vertically oriented cannabis operations now that a sale and leaseback agreement has been completed at the Toronto-area facility
• The 40,000-square-foot center is mostly completed; the company expects to build its first cultivation and extraction rooms by the end of the third quarter
• The company has a 19.9 percent stake in a Canadian retailer that grants CVGR access to store shelf space for its brands in Alberta and potentially elsewhere throughout the country
• CVGR plans to produce brands for the medicinal cannabis market and add edibles and infused beverage products as they become legal later this year
• The legal cannabis market is expected to continue growing worldwide at a CAGR of 23.9 percent through the end of 2025, reaching $66.3 billion in sales

Toronto-based City View Green Holdings Inc.’s (CSE: CVGR) vision of a purposeful seed-to-retail cannabis network is advancing thanks to the finalization of an agreement securing its operations in a 40,000-square-foot cultivation facility, where it intends to produce a pharmaceutical-grade crop.

City View Green recently announced that it had completed a previously detailed goal of transferring its option to purchase the facility in Brantford, Ontario, just southwest of Toronto, to an arms-length financier who has also completed a five-year renewable lease agreement with CVGR that includes a first right of refusal on any potential future sale of the property.

The financier will provide all the required buildout and capital improvements necessary for the mandatory Health Canada licenses and to make the facility a fully operational cannabis cultivation and extraction site, according to the announcement (http://ibn.fm/Qgorp). The new landlord obtained one million common share purchase warrants in exchange, each of which can be used to purchase one common share of the company at a price of $0.18 during the next five years.

The company further showed its intentions to keep a clean slate by closing on agreements to settle $580,019 in debt, under negotiated terms announced July 24.

“City View Green is pleased to close this transaction which provides non-dilutive financing to complete the buildout of our facility… and obtain the applicable Health Canada cannabis licensing to enter into full operations,” CEO Ian MacDonald stated in a news release.

The company expects to build the initial cultivation and extraction rooms within the building by the third quarter this year. Security features and general framework of the facility have already been completed.

CVGR is positioning itself to produce brands for the extract market and intends to add edibles as well as distillates and water-soluble products for cannabis-infused beverages once Canada completes legalization protocols for those markets, which is expected to occur in October, with the products themselves becoming available in mid-December (http://ibn.fm/sDyPQ).

City View Green has a 19.9 percent stake in Canadian retailer Budd Hutt Inc., which has stores in Alberta and potential retail agreements across the country. The Alberta stores are awaiting approval from the Alberta Gaming, Liquour and Cannabis division, but otherwise have all necessary licenses in place (http://ibn.fm/uG6T7).

CVGR sees the future of the industry as turning to recreational products, and the company intends to produce high-quality brands for both recreational adult-use consumers and medicinal/wellness consumers. The company is drawing on the experience of an expert extraction team and a master grower with a background in a top publicly listed cannabis issuer listed on the TSX Venture Exchange.

Canada’s first-mover position for national legalization of cannabis in North America grants it a lot of strength in advancing the economic interests of the country’s commerce at a time when cannabis and non-psychoactive hemp derivatives are enjoying a rush of societal interest and curiosity from investors as well as consumers. Market watcher Grand View Research predicts that the legal cannabis market will continue to grow worldwide at a CAGR of 23.9 percent through the end of 2025 and that it will reach $66.3 billion in sales by that point (http://ibn.fm/wcsRG).

For more information, visit the company’s website at www.CityViewGreen.ca

NOTE TO INVESTORS: The latest news and updates relating to CVGR are available in the company’s newsroom at http://ibn.fm/CVGR

• TGOD received a 100 percent organic rating from Toronto-based Corporate Knights magazine
• The company successfully renewed its Health Canada licenses authorizing the cultivation, processing and sale of cannabis from its Ancaster, Ontario, facility
• The cannabis company is lauded by the publication for its projected efficient, ecological use of renewable hydropower, which is scheduled to commence later this year

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), committed to production of organic cannabis, has been named one of the eco-friendliest cannabis firms in Canada. Corporate Knights, a Toronto-based publication, gave TGOD a 100 percent organic rating and cited its projected million square foot, ecologically efficient greenhouse in Valleyfield, Quebec (scheduled to operate later this year on renewable hydropower), as being a key component in the company’s anticipated growth (http://ibn.fm/jOxuA). As the budding cannabis industry continues to evolve, issues of sustainability and growing “greener” product are rising to the surface, and TGOD is currently one of only a handful of organic growers in Canada.

In an effort to meet the burgeoning market’s demand for product, cannabis producers have been focused on amassing large quantities of product. In this rush to produce, something has been neglected by most firms: tracking, disclosing and bettering their ESG (environment, social, governance) indicators. If sustainability efforts exist, they can mostly be found in the form of “cough[ed] up blurbs.” TGOD is ahead of the sustainability curve, however, joining 44 other cannabis growers to form the Global Cannabis Partnership. The Partnership published a Responsible Cannabis Framework setting up basic social responsibility standards for its partners. TGOD has become a leader among cannabis businesses wishing to adopt ‘greener’ practices and adhere to sustainability measures.

At the same time, TGOD has received renewal for its Health Canada licenses through August 2022, authorizing the cultivation, processing and sale of cannabis at its Ancaster, Ontario, facility (http://ibn.fm/2qMXa). Completion is expected by the end of August 2019 for TGOD’s third building at the site, a state-of-the-art hybrid greenhouse. That facility would bring the complex up to 166,000 square feet with an annual production capacity of 17,500 kilograms.

TGOD also received organic certification for its Valleyfield, Quebec, facility. TGOD anticipates that, when completed, this location will span up to 1.3 million square feet and become the largest organic-cannabis greenhouse in the world (http://ibn.fm/Ia5rZ). TGOD already has certified-organic growing facilities in Europe and Canada.

“From day one, the entire team at TGOD placed a strong focus on ethics and compliance,” TGOD CEO Brian Athaide stated in a news release. “These core values have been paramount to our success. Our team continues to work diligently as we ramp up production and execute our business plan.”

The plan targets the global CBD market, which the company sees reaching $22 billion in less than three years. TGOD is entering the global hemp-CBD market by debuting its global strategic hemp division. The move leverages the company’s expertise in the European hemp-CBD market across its in-place network of international partners (http://ibn.fm/uMJU2). That strategy includes several initiatives, including expansion in Canada, Germany, Jamaica, Mexico, Poland and the United States.

Toronto-based TGOD is a premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. Through wholly owned subsidiary HemPoland, TOGD distributes premium hemp-CBD oil in the European Union.

For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

• Sugarmade recently announced an initial investment in Kentucky’s Hempistry
• The company is in the process of acquiring leading hemp-supply firms that are currently producing more than $70 million in annual revenue
• Sugarmade has announced the completion of audits for BZRTH, a target acquisition

Sugarmade Inc. (OTCQB: SGMD), a product and brand marketing company investing in products and brands with disruptive potential, initially entered the burgeoning hemp sector through hydroponics. Today, Sugarmade is one of the leading providers of hydroponic equipment and supplies in the industrial hemp space.

A recent article discussed Kentucky’s hemp boom and the interest it is creating for investors (http://ibn.fm/0fvFH). The surge is providing an alternative crop for farmers struggling to make a living in the weakening farming industry. Sugarmade participates in supporting farmers through both investment and by offering necessary hydroponic supplies.

In 2014, Kentucky had 20 approved hemp growers across 33 acres in a trial run. By 2018, those numbers had increased to 210 growers and 6,700 cultivated acres. This sustained rapid expansion has been aided considerably by the passage of the 2018 Farm Bill; recent numbers indicate that 60,000 acres throughout the state are now devoted to hemp production, with nearly a thousand jobs created. Political support has helped Kentucky become the second-largest producer of hemp, while Colorado holds the number one spot.

Hempistry Inc. is a Kentucky-based hemp cultivator that began legal hemp cultivation in Western Kentucky last year. Sugarmade announced an initial investment of $190,000 in Hempistry (http://ibn.fm/na2SQ), part of a secured option to invest up to $1 million, that will allow the company to receive 12 percent of Hempistry’s biomass and converted distillate or isolate cannabidiol (CBD) profits for the upcoming 2019 farming season.

“We are also pleased to report we have made an initial investment in hemp cultivator Hempistry where Sugarmade will have a direct participation in the profits from this year’s hemp crop,” Sugarmade CEO Jimmy Chan noted in a news release. “Operations in Kentucky are well underway.”

Sugarmade is also in the process of acquiring several leading hemp-supply firms that are currently producing more than $70 million in annual revenue. BZRTH Inc., a hydronic-cultivation supplier, is a target acquisition of the company. Sugarmade recently announced that BZRTH has wrapped up its audits for previous financial periods, putting SGMD one step closer to finalizing the acquisition. The overall progress of the strategic move is dependent on completion of the audit – now done – and the availability of funds to close the transaction. Currently, $1 million has been paid toward closing the deal.

“The closing of the BZRTH audit provides Sugarmade with several more options for growth and our recently effective S-1 filing open doors for financing options,” Chan added. “We are analyzing several of these options in order to select the path for greatest shareholder maximization.”

Sugarmade is striving to be one of the largest publicly traded hydroponic supply companies and will continue to capitalize of the market boom through investment in the hemp and CBD spaces. In addition to expanding its North American footprint, Sugarmade is also expanding into the European hydroponics supply market, opening additional revenue opportunities. By 2025, the global hydroponics market is anticipated to reach $12.1 billion, with Europe dominating the industry (http://ibn.fm/V4TUs).

For more information, visit the company’s website at www.Sugarmade.com

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR